XenTech & Urosphere, two sister companies fully dedicated to preclinical oncology research, will be joining forces at this congress.

This joint presence reflects the strong complementarity that defines us, driven by our expanded coverage of model types and indications, as well as the depth of long-standing expertise we bring together and share for an integrated preclinical solution, from organoids to PDX models.

We’re excited to share that our scientific teams will present six research posters, showcasing new insights and innovations powered by this combined expertise.

Meet our experts at Booth #5036.

Let’s connect, explore your upcoming programs, and show you how Urosphere–Xentech can strengthen your oncology pipeline.